LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Convergent Therapeutics, Inc.

Similar companies to Convergent Therapeutics, Inc.

Convergent Therapeutics, Inc. Tech Stack

Convergent Therapeutics, Inc. uses 8 technology products and services including Google Analytics, Site Kit, Cloudflare, and more. Explore Convergent Therapeutics, Inc.'s tech stack below.

  • Google Analytics
    Analytics
  • Site Kit
    Analytics
  • Cloudflare
    Content Management System
  • Font Awesome
    Font Scripts
  • Swiper
    Javascript Libraries
  • PHP
    Programming Languages
  • X-XSS-Protection
    Security
  • Nginx
    Web Servers

Media & News

Convergent Therapeutics, Inc.'s Email Address Formats

Convergent Therapeutics, Inc. uses at least 1 format(s):
Convergent Therapeutics, Inc. Email FormatsExamplePercentage
First.Last@convergentrx.comJohn.Doe@convergentrx.com
47%
F-Last@convergentrx.comJ-Doe@convergentrx.com
3%
First.Last@convergentrx.comJohn.Doe@convergentrx.com
47%
F-Last@convergentrx.comJ-Doe@convergentrx.com
3%

Frequently Asked Questions

Where is Convergent Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Convergent Therapeutics, Inc.'s main headquarters is located at Cambridge, MA US. The company has employees across 1 continents, including North America.

What is Convergent Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Convergent Therapeutics, Inc.'s official website is convergentrx.com and has social profiles on LinkedIn.

How much revenue does Convergent Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of September 2024, Convergent Therapeutics, Inc.'s annual revenue reached $750K.

What is Convergent Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Convergent Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Convergent Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2024, Convergent Therapeutics, Inc. has approximately 16 employees across 1 continents, including North America. Key team members include Chief Financial Officer: E. S.Chief Medical Officer: R. M.Co-Founder & Chief Executive Officer: P. K.. Explore Convergent Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Convergent Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Convergent Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Convergent Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Convergent Therapeutics, Inc.'s tech stack includes Google AnalyticsSite KitCloudflareFont AwesomeSwiperPHPX-XSS-ProtectionNginx.

What is Convergent Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Convergent Therapeutics, Inc.'s email format typically follows the pattern of . Find more Convergent Therapeutics, Inc. email formats with LeadIQ.

How much funding has Convergent Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2024, Convergent Therapeutics, Inc. has raised $40M in funding. The last funding round occurred on Sep 24, 2024 for $40M.

When was Convergent Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Convergent Therapeutics, Inc. was founded in 2021.
Convergent Therapeutics, Inc.

Convergent Therapeutics, Inc.

Biotechnology ResearchMassachusetts, United States11-50 Employees

Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. 

Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer antigens. Building on breakthrough research developed by Dr. Neil Bander at Weill Cornell Medicine, Convergent has demonstrated that dual targeting of surface cancer molecules like Prostate-Specific Membrane Antigen (PSMA) improves antitumor efficacy. By leveraging targeting agents with different bio-distributions, such as monoclonal antibodies and ligands, supra-additive therapeutic doses are delivered to tumor cells without additive toxicity to the patient.

Section iconCompany Overview

Headquarters
Cambridge, MA US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2021
Employees
11-50

Section iconFunding & Financials

  • $40M

    Convergent Therapeutics, Inc. has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Sep 24, 2024 in the amount of $40M.

  • $10M

    Convergent Therapeutics, Inc.'s revenue is in the range of $10M

Section iconFunding & Financials

  • $40M

    Convergent Therapeutics, Inc. has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Sep 24, 2024 in the amount of $40M.

  • $10M

    Convergent Therapeutics, Inc.'s revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.